Table 5. Characteristics of findings in study of chronic HPgV-2 infection for participants with and without HCV co-infection in injection drug users in the San Francisco Bay area, California, USA*.
| Finding | HCV negative, n = 3 | HCV positive, n = 2 | p value |
|---|---|---|---|
| Average HPgV-2, log10 copies/mL | |||
| NS2/3 | 3.26 | 3.21 | 0.11 |
| 5′ UTR |
1.71 |
1.60 |
0.36 |
| Average years injection drug use† | 5.5 | 7.9 | NA |
| Average age at detection of HPgV-2 RNA, y† | 25.6 | 26.1 | NA |
*HCV, hepatitis C virus; HPgV-2, human pegivirus 2; NS, nonstructural protein. †No p values available because of low number of samples.